Spexis AG

SW:SPEX Switzerland Biotechnology
Market Cap
$317.64 Billion
CHF290.86 Billion CHF
Market Cap Rank
#31890 Global
#121 in Switzerland
Share Price
CHF4298.50
Change (1 day)
-4.87%
52-Week Range
CHF0.01 - CHF4564.00
All Time High
CHF4564.00
About

Spexis AG, a clinical-stage biopharmaceutical company, engages in discovering, developing, in-licensing, and acquiring molecules for rare diseases and cancer. Its products pipeline includes ColiFin, an inhaled colistimethate sodium product that is in the phase 3 trial for the treatment of cystic fibrosis (CF) infections; Inhaled Murepavadin, a novel class inhaled antibiotic which is in the phase … Read more

Spexis AG (SPEX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2023: -0.090x

Based on the latest financial reports, Spexis AG (SPEX) has a cash flow conversion efficiency ratio of -0.090x as of June 2023.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-1.55 Million) by net assets (CHF17.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Spexis AG - Cash Flow Conversion Efficiency Trend (2019–2023)

This chart illustrates how Spexis AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Spexis AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spexis AG ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Spexis AG (2019–2023)

The table below shows the annual cash flow conversion efficiency of Spexis AG from 2019 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 CHF2.29 Million CHF-5.48 Million -2.396x -288.76%
2022-12-31 CHF19.40 Million CHF-11.96 Million -0.616x -1552.40%
2021-12-31 CHF30.22 Million CHF-1.13 Million -0.037x +35.02%
2020-12-31 CHF13.49 Million CHF-774.29K -0.057x -190.76%
2019-12-31 CHF55.11 Million CHF-1.09 Million -0.020x --